Satiety hormone may decrease risk of Alzheimer's disease (1)

31 Jan 2019


Research, published in Neurobiology of Aging, suggests that individuals with high levels of the satiety hormone, cholecystokinin, may have a lower risk of developing Alzheimer's disease.

Science Daily


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story